Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shozo Okamoto

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Plos One|March 1, 2019
Voxel based comparison and texture analysis of 18F-FDG and 18F-FMISO PET of patients with head-and-neck cancerMarkus Kroenke, Kenji Hirata, Andrei Gafita, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 24, 2013
18F-fluoromisonidazole PET uptake is correlated with hypoxia-inducible factor-1α expression in oral squamous cell carcinomaJun Sato, Yoshimasa Kitagawa, Yutaka Yamazaki, et al.
Clinical Nuclear Medicine|January 22, 2015
FDG PET performed at thyroid remnant ablation has a higher predictive value for long-term survival of high-risk patients with well-differentiated thyroid cancer than radioiodine uptakeFlorian C Gaertner, Shozo Okamoto, Tohru Shiga, et al.
Odontology|October 27, 2015
Use of FDG-PET to detect a chronic odontogenic infection as a possible source of the brain abscessJun Sato, Takeshi Kuroshima, Mayumi Wada, et al.
Japanese Journal of Clinical Oncology|August 6, 2013
Histopathologic characterization of lung adenocarcinoma in relation to fluorine-18-fluorodeoxyglucose uptake on positron emission tomographyHiromitsu Domen, Yasuhiro Hida, Shozo Okamoto, et al.
Anticancer Research|February 11, 2014
Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancerJun Muto, Yasuhiro Hida, Kichizo Kaga, et al.
Annals of Nuclear Medicine|May 4, 2020
Biodistribution and internal radiation dosimetry of a novel probe for thymidine phosphorylase imaging, [<sup>123</sup>I]IIMU, in healthy volunteersShiro Watanabe, Ken-Ichi Nishijima, Shozo Okamoto, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2013
High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancerShozo Okamoto, Tohru Shiga, Koichi Yasuda, et al.
Annals of Nuclear Medicine|December 29, 2010
Semiquantitative analysis of C-11 methionine PET may distinguish brain tumor recurrence from radiation necrosis even in small lesionsShozo Okamoto, Tohru Shiga, Naoya Hattori, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 13, 2016
Comparison of bone scintigraphy and <sup>68</sup>Ga-PSMA PET for skeletal staging in prostate cancerThomas Pyka, Shozo Okamoto, Marielena Dahlbender, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Plos One|March 1, 2019
Voxel based comparison and texture analysis of 18F-FDG and 18F-FMISO PET of patients with head-and-neck cancerMarkus Kroenke, Kenji Hirata, Andrei Gafita, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 24, 2013
18F-fluoromisonidazole PET uptake is correlated with hypoxia-inducible factor-1α expression in oral squamous cell carcinomaJun Sato, Yoshimasa Kitagawa, Yutaka Yamazaki, et al.
Clinical Nuclear Medicine|January 22, 2015
FDG PET performed at thyroid remnant ablation has a higher predictive value for long-term survival of high-risk patients with well-differentiated thyroid cancer than radioiodine uptakeFlorian C Gaertner, Shozo Okamoto, Tohru Shiga, et al.
Odontology|October 27, 2015
Use of FDG-PET to detect a chronic odontogenic infection as a possible source of the brain abscessJun Sato, Takeshi Kuroshima, Mayumi Wada, et al.
Japanese Journal of Clinical Oncology|August 6, 2013
Histopathologic characterization of lung adenocarcinoma in relation to fluorine-18-fluorodeoxyglucose uptake on positron emission tomographyHiromitsu Domen, Yasuhiro Hida, Shozo Okamoto, et al.
Anticancer Research|February 11, 2014
Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancerJun Muto, Yasuhiro Hida, Kichizo Kaga, et al.
Annals of Nuclear Medicine|May 4, 2020
Biodistribution and internal radiation dosimetry of a novel probe for thymidine phosphorylase imaging, [<sup>123</sup>I]IIMU, in healthy volunteersShiro Watanabe, Ken-Ichi Nishijima, Shozo Okamoto, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2013
High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancerShozo Okamoto, Tohru Shiga, Koichi Yasuda, et al.
Annals of Nuclear Medicine|December 29, 2010
Semiquantitative analysis of C-11 methionine PET may distinguish brain tumor recurrence from radiation necrosis even in small lesionsShozo Okamoto, Tohru Shiga, Naoya Hattori, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 13, 2016
Comparison of bone scintigraphy and <sup>68</sup>Ga-PSMA PET for skeletal staging in prostate cancerThomas Pyka, Shozo Okamoto, Marielena Dahlbender, et al.
Pageof 4